🔧На сайте запланированы технические работы
25.12.2025 в промежутке с 18:00 до 21:00 по Московскому времени (GMT+3) на сайте будут проводиться плановые технические работы. Возможны перебои с доступом к сайту. Приносим извинения за временные неудобства. Благодарим за понимание!
🔧Site maintenance is scheduled.
Scheduled maintenance will be performed on the site from 6:00 PM to 9:00 PM Moscow time (GMT+3) on December 25, 2025. Site access may be interrupted. We apologize for the inconvenience. Thank you for your understanding!

 

Synthesis and In Vitro Neuroprotector Activity of Diastereoisomers of a Dimeric Dipeptide Mimetic of Nerve Growth Factor GK-2


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Previously, a dimeric dipeptide mimetic bis-(N-monosuccinyl-L-glutamyl-L-lysine) hexamethylenediamide (GK-2) based on the β-turn of the fourth loop of nerve growth factor was prepared by us, activated TrkA, and exhibited neuroprotective activity in vitro (10–5 – 10–9 M) and in vivo (0.05 – 5 mg/kg i.p.). The present work reports the synthesis of two of its diastereomers, bis-(N-monosuccinyl-L-glutamyl-D-lysine) (GK-2LD) and bis-(N-monosuccinyl-D-glutamyl-L-lysine) hexamethylenediamides (GK-2DL). Studies of their neuroprotective activities using HT-22 neuronal culture under oxidative stress showed that switching L-lysine to D-lysine led to a significant activity decrease whereas switching L-glutamic acid to the D-stereoisomer caused it to disappear completely. Both dipeptide residues were concluded to be involved in interactions with the TrkA receptor.

About the authors

N. M. Sazonova

V. V. Zakusov State Institute of Pharmacology, Russian Academy of Medical Sciences

Author for correspondence.
Email: saz-nelly@mail.ru
Russian Federation, 8 Baltiiskaya, Moscow, 125315

A. V. Tarasyuk

V. V. Zakusov State Institute of Pharmacology, Russian Academy of Medical Sciences

Email: saz-nelly@mail.ru
Russian Federation, 8 Baltiiskaya, Moscow, 125315

A. N. Shumskii

V. V. Zakusov State Institute of Pharmacology, Russian Academy of Medical Sciences

Email: saz-nelly@mail.ru
Russian Federation, 8 Baltiiskaya, Moscow, 125315

A. G. Rebeko

V. V. Zakusov State Institute of Pharmacology, Russian Academy of Medical Sciences

Email: saz-nelly@mail.ru
Russian Federation, 8 Baltiiskaya, Moscow, 125315

P. I. Antipov

V. V. Zakusov State Institute of Pharmacology, Russian Academy of Medical Sciences

Email: saz-nelly@mail.ru
Russian Federation, 8 Baltiiskaya, Moscow, 125315

I. O. Logvinov

V. V. Zakusov State Institute of Pharmacology, Russian Academy of Medical Sciences

Email: saz-nelly@mail.ru
Russian Federation, 8 Baltiiskaya, Moscow, 125315

T. A. Antipova

V. V. Zakusov State Institute of Pharmacology, Russian Academy of Medical Sciences

Email: saz-nelly@mail.ru
Russian Federation, 8 Baltiiskaya, Moscow, 125315

T. A. Gudasheva

V. V. Zakusov State Institute of Pharmacology, Russian Academy of Medical Sciences

Email: saz-nelly@mail.ru
Russian Federation, 8 Baltiiskaya, Moscow, 125315

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2018 Springer Science+Business Media, LLC, part of Springer Nature